iSpecimen and myOnsite Deploy Mobile Phlebotomy During Coronavirus Pandemic
iSpecimen has announced a new initiative in the battle against COVID-19 and other diseases, mobile phlebotomy support that will bring at-home sample collection to patients and donors interested in advancing research. The mobile service extends iSpecimen’s ongoing mission to advance medical research by connecting researchers with patients, biospecimens, and the data they need to perform their work.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025